Morning Ireland podcast

Immunising infants and older people against RSV found to not be cost-effective - HIQA

0:00
2:54
Manda indietro di 15 secondi
Manda avanti di 15 secondi
Dr. Máirín Ryan, HIQA Director of Health Technology Assessment, explains its assessment of immunisation programmes against RSV.

See omnystudio.com/listener for privacy information.

Altri episodi di "Morning Ireland"